FR3104945B3 - Hydrogel à base d’un dérivé hydroxyphényle réticulé d’acide hyaluronique - Google Patents

Hydrogel à base d’un dérivé hydroxyphényle réticulé d’acide hyaluronique Download PDF

Info

Publication number
FR3104945B3
FR3104945B3 FR2009046A FR2009046A FR3104945B3 FR 3104945 B3 FR3104945 B3 FR 3104945B3 FR 2009046 A FR2009046 A FR 2009046A FR 2009046 A FR2009046 A FR 2009046A FR 3104945 B3 FR3104945 B3 FR 3104945B3
Authority
FR
France
Prior art keywords
hyaluronic acid
crosslinked
hydrogel based
hydroxyphenyl derivative
hydroxyphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2009046A
Other languages
English (en)
Other versions
FR3104945A3 (fr
Inventor
Evgeniy Toropitsyn
Martin Pravda
Lenka Kovarova
Julie Bystronova
Vladimir Velebny
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Contipro AS
Original Assignee
Contipro AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Contipro AS filed Critical Contipro AS
Publication of FR3104945A3 publication Critical patent/FR3104945A3/fr
Application granted granted Critical
Publication of FR3104945B3 publication Critical patent/FR3104945B3/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L101/00—Compositions of unspecified macromolecular compounds
    • C08L101/12—Compositions of unspecified macromolecular compounds characterised by physical features, e.g. anisotropy, viscosity or electrical conductivity
    • C08L101/14—Compositions of unspecified macromolecular compounds characterised by physical features, e.g. anisotropy, viscosity or electrical conductivity the macromolecular compounds being water soluble or water swellable, e.g. aqueous gels
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

Hydrogel à base d’un dérivé hydroxyphényle réticulé d’acide hyaluronique La présente invention concerne un hydrogel à base d’un dérivé hydroxyphényle réticulé de l’acide hyaluronique, caractérisé en ce qu’il contient des molécules d’un dérivé hydroxyphényle de l’acide hyaluronique (HA-TA), ou du sel pharmaceutiquement acceptable de celui-ci, et du sulfate de chondroïtine, ou du sel de celui-ci pharmaceutiquement acceptable, sélectionné dans un groupe comprenant des sels alcalins ou des sels alcalino-terreux.
FR2009046A 2019-09-06 2020-09-07 Hydrogel à base d’un dérivé hydroxyphényle réticulé d’acide hyaluronique Active FR3104945B3 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ2019-36602U CZ33324U1 (cs) 2019-09-06 2019-09-06 Hydrogel na bázi zesíťovaného hydroxyfenylového derivátu kyseliny hyaluronové
CZPUV2019-36602 2019-09-06

Publications (2)

Publication Number Publication Date
FR3104945A3 FR3104945A3 (fr) 2021-06-25
FR3104945B3 true FR3104945B3 (fr) 2021-12-10

Family

ID=68384244

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2009046A Active FR3104945B3 (fr) 2019-09-06 2020-09-07 Hydrogel à base d’un dérivé hydroxyphényle réticulé d’acide hyaluronique

Country Status (6)

Country Link
AT (1) AT18104U1 (fr)
CZ (1) CZ33324U1 (fr)
DE (1) DE212020000715U1 (fr)
FR (1) FR3104945B3 (fr)
SK (1) SK9649Y1 (fr)
WO (1) WO2021043349A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ308970B6 (cs) * 2020-05-12 2021-10-27 Contipro A.S. Sada gelotvorných roztoků určená pro přípravu hydrogelu na bázi kovalentně zesítěného hydroxyfenylového derivátu hyaluronanu k prevenci pooperačních komplikací souvisejících s vytvořením kolorektální anastomózy a její použití

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU555747B2 (en) 1983-08-09 1986-10-09 Cilco Inc. Chondroitin sulfate and sodium hyaluronate composition
US6051560A (en) 1986-06-26 2000-04-18 Nestle S.A. Chrondroitin sulfate/sodium hyaluronate composition
DE10156617A1 (de) 2001-11-17 2003-05-28 Biosphings Ag Herstellung reiner Stereoisomere von Tricyclo[5.2.1.0··2··.··6··]-dec-9-yl-xanthogenat und Arzneimittel daraus
ATE525076T1 (de) 2002-10-16 2011-10-15 Arthrodynamic Technologies Animal Health Division Inc Behandlung von traumatischer synovitis und geschädigtem gelenkknorpel
US6982298B2 (en) 2003-01-10 2006-01-03 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US7465766B2 (en) * 2004-01-08 2008-12-16 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
CN101052684B (zh) 2004-07-09 2014-02-12 克利夫兰临床基金会 羟基苯交联大分子网络及其应用
US8394782B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
KR101091028B1 (ko) * 2009-07-02 2011-12-09 아주대학교산학협력단 체내 주입형 하이드로젤 및 이의 생의학적 용도
KR101161640B1 (ko) * 2009-08-25 2012-07-02 서울과학기술대학교 산학협력단 리포산이 결합된 화합물과 이의 제조방법
EP3067069B1 (fr) * 2009-11-11 2023-07-26 Hy2Care B.V. Hydrogels à base de polymères de dextrane-tyramine et conjugués tyramine de polymères naturels
CZ28434U1 (cs) * 2015-05-18 2015-07-07 Contipro Biotech S.R.O. Nanokompozit na bázi hydroxyfenylového derivátu kyseliny hyaluronové nebo jejísoli obsahující nanočástice fosforečnanu vápenatého

Also Published As

Publication number Publication date
WO2021043349A1 (fr) 2021-03-11
SK9649Y1 (sk) 2022-11-24
CZ33324U1 (cs) 2019-10-25
SK500272022U1 (sk) 2022-07-27
FR3104945A3 (fr) 2021-06-25
DE212020000715U1 (de) 2022-04-21
AT18104U1 (de) 2024-02-15

Similar Documents

Publication Publication Date Title
DK1948131T3 (da) Dexpanthenol-, calciumion- og phosphatfri farmaceutisk sammensætning samt anvendelse af calciumchelatdannere og oftalmologisk kompatible viskositetsregulatorer
BR112017024164A2 (pt) aparelho, sistema e método de determinação de um ou mais parâmetros óticos de uma lente
EA202092086A1 (ru) Ингибиторы аргиназы
BR112018071585A2 (pt) formulações de um inibidor de lsd1
MA44674A (fr) Inhibiteurs de bromodomaine
BR112016029714A2 (pt) sistema de câmeras múltiplas que usa óptica dobrada livre de artefatos de inclinação e paralaxe
MA40123A1 (fr) Pyrimidines utilisées en tant qu'inhibiteurs du facteur xia
FR3104945B3 (fr) Hydrogel à base d’un dérivé hydroxyphényle réticulé d’acide hyaluronique
EA201691484A1 (ru) Соли и твердая форма ингибитора btk
BR112017018416A2 (pt) método para determinação de uma lente oftálmica tendo astigmatismo indesejado
EA201290894A1 (ru) Азетидиновые производные пиперидин-4-ила как ингибиторы jak1
MX2022015745A (es) Sistema de construcción estructural mediante modelado arquitectónico.
TW201614330A (en) Image display device
MX2019011116A (es) Inhibidores de la tirosina quinasa de bruton.
MA38633B1 (fr) Système à lots multiples pour la préparation d'une solution de bicarbonate de calcium convenant à la reminéralisation d'eau dessalée et d'eau naturellement douce
BR112017003415A2 (pt) método e sistema para processamento de um reembolso em tempo real em autorização de transação
NZ760749A (en) Bicyclic ketone compounds and methods of use thereof
MA41633B1 (fr) Composés amide en tant qu'agonistes du récepteur 5-ht4
BR112017022208A2 (pt) sistema espinhal poliaxial expansível
BR112016028639A2 (pt) composição de tintura de cabelo
ATE391938T1 (de) Optisches system für eine funduskamera
MX2024002139A (es) Arilsulfonil(hidroxi)piperidinas como inhibidores de ccr6.
EP2617921A3 (fr) Système comportant un profilé creux et une patte de fixation d'une charnière, ainsi que patte de fixation
BR112017013817A8 (pt) Amortecedor de retenção de lente de óculos, óculos configurável pelo usuário e método
MX2023000919A (es) Inhibidores de factores del complemento y usos de los mismos.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5